By Maggie Fick and Stine Jacobsen LONDON/COPENHAGEN (Reuters) -Shares in Novo Nordisk fell as much as 3.5% on Monday after ...

Novo Nordisk’s new weight-loss drug helped patients lose even more weight on average than its current Wegovy blockbuster ...

Separately, Novo Nordisk presented early data for its oral amycretin program. In Phase I and Ib/IIa trials, amycretin ...

New data from a Phase 3 trial show that the daily anti-obesity pill may be as safe and effective as drugs like Mounjaro and ...

An obesity drug from China helped patients lose a lot of weight in a late-stage clinical trial, making it a prospective new ...

Novo Nordisk’s next-gen weight loss drug and Zepbound “seem fairly equal to me,” one expert says after release of new ...

While some compounding pharmacies have stopped making alternatives to Wegovy and Zepbound since shortages were declared over, ...

A new drug is helping families who've spent years padlocking fridges, chaining garbage cans, and hiding food as their ...

Nearly 1 in 4 people have sarcopenic obesity, a dangerous condition mixing muscle loss and weight gain. Learn the warning signs and prevention tips.

Obesity caused by a high-fat Western diet damages the pancreas, affecting insulin production and blood sugar control even ...

For patients with obesity, clinicians should move beyond a "try and fail" approach to lifestyle interventions and prioritize ...

Projections show half of ten and 11-year-olds could be overweight or obese in some areas, with experts calling for urgent ...